Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0000899243-21-027015

CHIEF OPERATING OFFICER acquired 8,126 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Stultz Katherine V CHIEF OPERATING OFFICER 2021-06-29 Conversion +8,126 216,020 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Stultz Katherine V CHIEF OPERATING OFFICER 2021-01-13 Grant or award · Stock Option (right to buy) +99,753 99,753 D: show line 2 in the form
Stultz Katherine V CHIEF OPERATING OFFICER 2021-03-11 Grant or award · Series B Preferred Stock +19,763 $5.06 $100,001 19,763 D: show line 3 in the form
Stultz Katherine V CHIEF OPERATING OFFICER 2021-03-17 Grant or award · Stock Option (right to buy) +209,846 209,846 D: show line 4 in the form
Stultz Katherine V CHIEF OPERATING OFFICER 2021-03-17 Grant or award · Stock Option (right to buy) +89,934 89,934 D: show line 5 in the form
Stultz Katherine V CHIEF OPERATING OFFICER 2021-06-29 Conversion · Series B Preferred Stock −19,763 0 D: show line 6 in the form
Loading xslF345X03/doc4.xml…